Abstract:Young women with breast cancer are at higher risk of locoregional recurrence in comparison with elder women. The study aimed to determine the factors related to locoregional recurrence and the impact of post-mastectomy radiotherapy in women ≤35 years old. Between February 1989 and December 2004, 459 patients ≤35 years old with operable breast cancer who treated mastectomy were retrospectively analyzed. The type of surgery included: radical mastectomy (47.4%), extended radical mastectomy (11.5%) and modified radical mastectomy (MRM; 39.6%). The percentage for T1, T2, and T3 tumor was 22.0%, 52.3%, and 10.0%, respectively. Lymph node without metastasis accounted for 25.7% of all and N1, N2, and N3 lymph node accounted for 25.5%, 20.7%, and 14.6%. Four hundred twenty-three patients received chemotherapy and 160 patients received endocrine therapy. PMRT was administered in 220 patients (47.9%). Radiation field included supraclavicular lymph node and internal mammary nodes only in 187 and 170 patients while chest wall was treated in 25 patients. Median age of this cohort was 32 years old and median follow-up was 50.1 months. The median disease-free interval to first isolated locoregional recurrence was 17.8 ± 2.7 months. The 5-year and 10-year isolated locoregional control rate (ILRCR) was 74.9% and 70.0%, respectively. The most common site of recurrence was CW (106/131) followed by SN (18/131). The 5-year CW control rate decreased with more advanced T and N Stage (p<0.05). Compared to the patients with no ILR, patients with ILR had a shorter 5-year metastasis-free survival (MFS) (66.6% vs. 53.8%; p = 0.003). In univariate analysis, surgical modality, tumor size, lymph node status, chemotherapy and ILR were significant predictors for overall survival (OS). In multivariate analysis, only higher T-Stage (p = 0.041; HR = 1.69; 95% CI = 1.02 – 2.16) was the independent predictor for isolated chest-wall recurrence (ICWR) while higher N-Stage (p = 0.005; HR = 1.58; 95% CI = 1.15 – 2.78) was the additional predictor for ILR besides higher T-Stage (p = 0.047; HR = 1.58; 95% CI = 1.02 – 2.42). Higher T-Stage (p = 0.014; HR = 1.52; 95% CI = 1.09 – 2.12), higher N-Stage (p < 0.001; HR = 2.25; 95% CI = 1.67 – 3.03), the use of endocrine therapy (p = 0.014; HR = 0.59; 95% CI = 0.39 – 0.90) and ICWR (p = 0.006; HR = 1.87; 95% CI = 1.20 – 2.91) are independent predictors for MFS. As to OS, all factors above were independent prognostic factors for OS except for the endocrine therapy administration (p > 0.05). Young women with operable breast cancer receiving mastectomy have a high risk of ILR and shorter disease-free interval. It is critical to re-evaluate the impact of PMRT in young patients. Chest-wall remains the region with higher risk of recurrence and should not be neglected as PMRT target.

Mould Brachyradiotherapy for Recurrence of Breast Cancer on Chest Wall

A dosimetric comparison of the tangential beams IMRT with multifield beams IMRT of the chest wall in postmastectomy breast cancer recurrent patients

Study of Late Course Three Dimensional-Conformal Radiotherapy Combined with Chemotherapy for 29 Cases with Recurrent Rectal Cancer.

125I Brachytherapy of Locally Advanced Non-Small-cell Lung Cancer after One Cycle of First-Line Chemotherapy: a Comparison with Best Supportive Care.

Radiotherapy for 64 Cases with Postoperative Chestwall Local Recurrence of Breast Cancer

Radiotherapy for chest wall recurrence of breast cancer after mastectomy

Clinical Value of Radiotherapy in 78 Patients with Pt3 N0 M0 Breast Cancer after Modified Radical Mastectomy

Safety and efficacy of stereotactic ablative brachytherapy as a salvage therapy for recurrent chest wall cancer: A retrospective, multicenter study

Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial.

Radiotherapy for and Prognosis of Breast Cancer Patients with Local-Regional Recurrence after Mastectomy

Integrated IMRT Vs Segmented 3D-CRT of the Chest Wall and Supraclavicular Region for Breast Cancer after Modified Radical Mastectomy: an 8-Year Follow-Up

The Radiotherapy after the Conservative Surgery for Patients with Breast Cancer-Technology and Indication

Preliminary Application of 192 Ir High-Dose Rate Brachytherapy in Postoperative Recurrent Colorectal Cancer with Intrapulmonary Oligometastases

Curative Effect of 3-Dimensional Conformal Radiotherapy for Recurrence Cervix Cancer:Report of 42 Cases

Three-Dimensional-Printed Template-Guided Radioactive Seed Brachytherapy Via a Submental Approach for Recurrent Base of Tongue and Floor of Mouth Cancer

Locoregional Recurrence Analysis in Young Women (≤35 Years) Receiving Mastectomy with Operable Breast Cancer

Prognosis and Prophylactic Regional Nodal Irradiation in Breast Cancer Patients With the First Isolated Chest Wall Recurrence After Mastectomy

Radiotherapy following modified radical mastectomy significantly improves locoregional control in patients with Rec-/HER-2+ locally advanced breast cancer

Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose

Controlling Postoperative Recurrence of Oral Carcinomas with Intracavity Brachytherapy

Interstitial 125I Brachytherapy As a Salvage Treatment for Refractory Cervical Lymph Node Metastasis of Thoracic Esophageal Squamous Cell Carcinoma after External Irradiation with a CT-Guided Coplanar Template-Assisted Technique: A Retrospective Study.